6 Factors controlling blood concentration of somatomedin C (Q40109950)

17 September 2017

1 reference

reason for preferred rank

title

6 Factors controlling blood concentration of somatomedin C (English)

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(84)80011-0

27 August 2023

Factors controlling blood concentration of somatomedin C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6202444

27 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(84)80011-0

27 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(84)80011-0

27 August 2023

D. R. Clemmons

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6202444

27 August 2023

J. J. Van Wyk

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6202444

27 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6202444

27 August 2023

publication date

1 March 1984

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:S0300595X84800110?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0300-595X(84)80011-0

https://api.elsevier.com/content/article/PII:S0300595X84800110?httpAccept=text/plain

27 August 2023

1 reference

DOI

https://api.crossref.org/works/10.1016/S0300-595X(84)80011-0

Clinics in Endocrinology and Metabolism

27 August 2023

published in

1 reference

17 September 2017

1 reference

17 September 2017

1 reference

17 September 2017

page(s)

113-143

1 reference

Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats.

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Developmental patterns of insulin-like growth factor-I and -II synthesis and regulation in rat fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Studies on sulfation factor (SF) activity of human serum. The variation of serum SF with age

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Studies on sulfation factor (SF) activity of human serum. Serum SF in hypopituitarism and acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Subunit structure and amino acid composition of mouse submaxillary gland nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Radioimmunoassay of a Basic Somatomedin: Comparison of Various Assay Techniques and Somatomedin Levels in Various Sera*

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Somatomedin-C Mediates Growth Hormone Negative Feedback by Effects on Both the Hypothalamus and the Pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

The Effect of Hypothyroidism on Growth, Serum Growth Hormone, the Growth Hormone-Dependent Somatomedin, Insulin-Like Growth Factor, and Its Carrier Protein in Rats*

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Effect of in Vitro Action of Serum Proteases or Exposure to Acid on Measurable Immunoreactive Somatomedin-C in Serum*

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Growth hormone secretion and plasma somatomedin-C in primary hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Somatomedin-C and platelet-derived growth factor stimulate human fibroblast replication

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-C

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Estradiol treatment of acromegaly. Reduction of immunoreactive somatomedin-C and improvement in metabolic status

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Reduction of plasma immunoreactive somatomedin C during fasting in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Liberation of Immunoreactive Somatomedin-C from Its Binding Proteins by Proteolytic Enzymes and Heparin*

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Induction of immunoreactive somatomedin C human serum by growth hormone: dose-response relationships and effect on chromatographic profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Measurement of somatomedin by cartilage in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Sulfation factor activity of sera from patients with pituitary disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extractio

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

The effect of growth hormone treatment on somatomedin levels in growth hormone-deficient children

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Serum somatomedin-C in hypopituitarism and in other disorders of growth

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

A partially purified polypeptide fraction from rat liver cell conditioned medium with multiplication-stimulating activity for embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Non-suppressible insulin-like activity of human serum. II. Biological properties of plasma extracts with non-suppressible insulin-like activity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

The somatomedin C binding protein: evidence for a heterologous subunit structure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Pitfalls in the somatomedin-C radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Serum immunoreactive somatomedin-C is elevated late in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Uremia reduces serum insulin-like growth factor I, increases insulin-like growth factor II, and modifies their serum protein binding

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Effect of intravenous administration of human growth hormone on sulphation factor activity in serum of hypopituitary subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Some biological properties of purified sulfation factor (SF) from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Nonsuppressible Insulin-Like Activity (NSILA).II. Regulation of Serum Concentrations by Growth Hormone and Insulin*

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Demonstration of specific plasma protein binding sites for somatomedin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Plasma somatomedin and growth hormone values in children with protein-calorie malnutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Plasma Somatomedin-Binding Proteins in Hypopituitarism: Changes during Growth Hormone Therapy*

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Further Comparisons of the [125I]Somatomedin A and the [125I]Somatomedin C Radioreceptor Assays of Somatomedin Peptide*

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Comparison of [125I]Somatomedin A and [125I]Somatomedin C Radioreceptor Assays for Somatomedin Peptide Content in Whole and Acid-Chromatographed Plasma*

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Ovine placental lactogen induces somatomedin: a a possible role in fetal growth

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Dietary components that regulate serum somatomedin-C concentrations in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Alteration of Cartilage Glycosaminoglycan Protein Acceptor by Somatomedin and Cortisol

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Sequence analysis of somatomedin-C: confirmation of identity with insulin-like growth factor I

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Characterization of the insulin and somatomedin-C receptors in human placental cell membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Insulin-like growth factors in the fed and fasted states.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Decreased serum somatomedin C concentrations during sleep: temporal relationship to the nocturnal surges of growth hormone and prolactin.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Plasma somatomedin-C as a screening test for growth hormone deficiency in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Structure of somatomedin-binding protein: alkaline pH-induced dissociation of an acid-stable, 60,000 molecular weight complex into smaller components

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Growth hormone, somatomedin and cartilage sulfation in failure of catch-up growth after propylthiouracil-induced hypothyroidism in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Nutritional regulation of somatomedin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Nutrition and somatomedin. I. Effect of fasting and refeeding on serum somatomedin activity and cartilage growth activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Somatomedin and nutrition. IV. Regulation of somatomedin activity and growth cartilage activity by quantity and composition of diet in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Purified Human Somatomedin A and Rat Multiplication Stimulating Activity. Mitogens for Cultured Fibroblasts that Cross-React with the Same Growth Peptide Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

The use of a commercially available somatomedin-C radioimmunoassay in patients with disorders of growth

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

The relation between growth velocity and serum somatomedin C concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Children with normal-variant short stature: treatment with human growth hormone for six months

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Nonsuppressible insulin-like activity (NSILA). I. Development of a new sensitive competitive protein-binding assay for determination of serum levels

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Increased plasma somatomedin reactivity in chronic renal failure as determined by acid gel filtration and radioreceptor assay

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Non-suppressible insulin-like activity and sulphaton activity in serum extracts of normal subjects, acromegalics and pituitary dwarfs

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Somatomedin C in treated acromegaly: poor correlation with growth hormone and clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Somatomedin A in human serum, determined by radioreceptor assay

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Serum somatomedin peptides measured by somatomedin A radioreceptor assay in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Serum Somatomedin A in Chronic Renal Failure*

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Somatomedin-C and the assessment of growth

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Further Purification and Characterization of Sulfation Factor and Thymidine Factor from Acromegalic Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Changes in circulating somatomedin-C levels in bromocriptine-treated acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Suppression of growth hormone-dependent human serum sulfation factor by estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

The insulin-like growth factors (IGF) of human serum: chemical and biological characterization and aspects of their possible physiological role.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Binding of nonsuppressible insulinlike activity to human serum. Evidence for a carrier protein

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Evidence for the existence in human serum of large molecular weight nonsuppressible insulin-like activity (NSILA) different from the small molecular weight forms

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Nonsuppressible insulin-like activity (NSILA) from human serum: Recent accomplishments and their physiologic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Inhibition of the Action of Nonsuppressible Insulin-Like Activity on Isolated Rat Fat Cells by Binding to its Carrier Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2884%2980011-0

7 January 2021

Synchronous activation of DNA synthesis in hypophysectomized rat cartilage by growth hormone

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(84)80011-0

Competitive Binding of Somatomedin to the Insulin Receptors of Adipocytes, Chondrocytes, and Liver Membranes

27 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(84)80011-0

27 August 2023

Identifiers

DOI

1 reference

17 September 2017

1 reference